Rate of Hospitalizations and Underlying Reasons Among People with Parkinson's Disease: Population-Based Cohort Study in UK Primary Care.


Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2022
Historique:
pubmed: 2 11 2021
medline: 28 4 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

Hospitalization in Parkinson's disease (PD) is associated with reduced quality of life, caregiver burden and high costs. However, no large-scale studies of rate and causes of hospitalizations in patients with PD have been published. To investigate the rate and reasons for hospitalization and factors associated with hospitalization among people with PD compared to the general population. We examined rate and causes of admission in PD patients and matched controls in The Health Improvement Network from 2006 to 2016. Multivariable Poisson regression was used to explore the effects of age, gender, social deprivation, urbanicity and practice geographic location on hospitalization. In the longitudinal data from 9,998 newly diagnosed individuals with PD and 55,554 controls without PD aged ≥50 years, 39% of PD patients and 28% of controls were hospitalised over a median follow-up of 5.1 years. The adjusted incidence rate ratio (IRR) of hospitalization in PD compared to controls was 1.33 (95% CI:1.29-1.37) and rose with increased follow-up duration. Hospitalization rate was overall higher in the older age groups, but the adjusted IRR of hospitalization compared to controls was highest in the youngest age group. PD patients were more often admitted with falls/fractures, infections, gastrointestinal complications, PD, dementia, psychosis/hallucinations, postural hypotension, electrolyte disturbances, stroke and surgical procedures and slightly less often due to hypertension. People with PD have an increased hospitalization rate compared to controls, particularly in the younger age groups, and it increases with longer disease duration. The complications of motor and non-motor features of PD are amongst the main reasons for admission, some of which could be managed preventatively to avoid admissions.

Sections du résumé

BACKGROUND
Hospitalization in Parkinson's disease (PD) is associated with reduced quality of life, caregiver burden and high costs. However, no large-scale studies of rate and causes of hospitalizations in patients with PD have been published.
OBJECTIVE
To investigate the rate and reasons for hospitalization and factors associated with hospitalization among people with PD compared to the general population.
METHODS
We examined rate and causes of admission in PD patients and matched controls in The Health Improvement Network from 2006 to 2016. Multivariable Poisson regression was used to explore the effects of age, gender, social deprivation, urbanicity and practice geographic location on hospitalization.
RESULTS
In the longitudinal data from 9,998 newly diagnosed individuals with PD and 55,554 controls without PD aged ≥50 years, 39% of PD patients and 28% of controls were hospitalised over a median follow-up of 5.1 years. The adjusted incidence rate ratio (IRR) of hospitalization in PD compared to controls was 1.33 (95% CI:1.29-1.37) and rose with increased follow-up duration. Hospitalization rate was overall higher in the older age groups, but the adjusted IRR of hospitalization compared to controls was highest in the youngest age group. PD patients were more often admitted with falls/fractures, infections, gastrointestinal complications, PD, dementia, psychosis/hallucinations, postural hypotension, electrolyte disturbances, stroke and surgical procedures and slightly less often due to hypertension.
CONCLUSION
People with PD have an increased hospitalization rate compared to controls, particularly in the younger age groups, and it increases with longer disease duration. The complications of motor and non-motor features of PD are amongst the main reasons for admission, some of which could be managed preventatively to avoid admissions.

Identifiants

pubmed: 34719512
pii: JPD212874
doi: 10.3233/JPD-212874
pmc: PMC7612266
mid: EMS138301
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-420

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209207
Pays : United Kingdom

Références

Cancer Causes Control. 2010 May;21(5):697-707
pubmed: 20054708
NPJ Parkinsons Dis. 2015 Jun 11;1:15011
pubmed: 28409181
Parkinsons Dis. 2012;2012:543426
pubmed: 22496990
J Neurol. 2002 Apr;249(4):419-23
pubmed: 11967646
J Neurol. 2013 Jul;260(7):1752-6
pubmed: 23412356
Parkinsonism Relat Disord. 2020 Dec;81:123-128
pubmed: 33120073
Mov Disord. 2005 Nov;20(11):1449-54
pubmed: 16007641
Clin Epidemiol. 2018 Sep 04;10:1147-1154
pubmed: 30233249
J Bone Joint Surg Am. 2014 Feb 19;96(4):e27
pubmed: 24553896
Dysphagia. 2016 Feb;31(1):24-32
pubmed: 26590572
Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):443-51
pubmed: 15898131
Acta Neurol Scand. 2001 Jan;103(1):7-11
pubmed: 11153892
Parkinsonism Relat Disord. 2013 Aug;19(8):737-41
pubmed: 23680419
PLoS One. 2016 Sep 01;11(9):e0161689
pubmed: 27583564
Parkinsonism Relat Disord. 2014 May;20(5):488-92; discussion 488
pubmed: 24582073
Mov Disord. 2004 Jan;19(1):49-53
pubmed: 14743360
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):324-30
pubmed: 24876185
J Clin Epidemiol. 1995 Mar;48(3):431-43
pubmed: 7897464
Neurology. 2003 Jan 14;60(1):87-93
pubmed: 12525724
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):76-83
pubmed: 19065600
BMC Neurol. 2012 Mar 08;12:13
pubmed: 22400982
Parkinsonism Relat Disord. 2013 Nov;19(11):949-54
pubmed: 23835430
BMJ. 1990 Apr 28;300(6732):1092
pubmed: 2344534
Neurology. 2007 Oct 23;69(17):1696-700
pubmed: 17954784
Nat Rev Neurol. 2017 Feb;13(2):81-95
pubmed: 28106066
Pract Neurol. 2020 Feb;20(1):15-25
pubmed: 31427383
Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):704-7
pubmed: 19455565
Parkinsonism Relat Disord. 2010 Mar;16(3):186-90
pubmed: 19945903
Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):64-9
pubmed: 23124958
Parkinsonism Relat Disord. 2020 Feb;71:66-72
pubmed: 32156461
Behav Neurol. 2013 Jan 1;27(4):469-77
pubmed: 23242358
Dysphagia. 2009 Mar;24(1):91-102
pubmed: 18931877
Langenbecks Arch Surg. 2009 May;394(3):511-5
pubmed: 18712410
Acta Neurol Scand. 2010 Jan;121(1):38-43
pubmed: 19744137

Auteurs

Olaitan Okunoye (O)

Department of Clinical and Movement Neurosciences, University College London, UK.

Laura Horsfall (L)

Department of Primary Care and Population Health, University College London, UK.

Louise Marston (L)

Department of Primary Care and Population Health, University College London, UK.

Kate Walters (K)

Department of Primary Care and Population Health, University College London, UK.

Anette Schrag (A)

Department of Clinical and Movement Neurosciences, University College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH